DCAF16-Based Covalent Handle for the Rational Design of Monovalent Degraders
ACS Central Science · 24.07.2024 · 10 (7) · 1318-1331
DOI: 10.1021/acscentsci.4c00286 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Central Science, online erschienen am 17.05.2024. Verfasst von Melissa Lim und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of California, Berkeley, Berkeley, California 94720, United States. Die Arbeit wurde bisher 110-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, Division of Chemistry.
Abstract (Originalsprache)
Targeted protein degradation with monovalent molecular glue degraders is a powerful therapeutic modality for eliminating disease causing proteins. However, rational design of molecular glue degraders remains challenging. In this study, we sought to identify a transplantable and linker-less covalent handle that could be appended onto the exit vector of various protein-targeting ligands to induce the degradation of their respective targets. Using the BET family inhibitor JQ1 as a testbed, we synthesized and screened a series of covalent JQ1 analogs and identified a vinylsulfonyl piperazine handle that led to the potent and selective degradation of BRD4 in cells. Through chemoproteomic profiling, we identified DCAF16 as the E3 ligase responsible for BRD4 degradation-an E3 ligase substrate receptor that has been previously covalently targeted for molecular glue-based degradation of BRD4. Interestingly, we demonstrated that this covalent handle can be transplanted across a diverse array of protein-targeting ligands spanning many different protein classes to induce the degradation of CDK4, the androgen receptor, BTK, SMARCA2/4, and BCR-ABL/c-ABL. Our study reveals a DCAF16-based covalent degradative and linker-less chemical handle that can be attached to protein-targeting ligands to induce the degradation of several different classes of protein targets.
Autor:innen und Institutionen
- Department of Chemistry, University of California, Berkeley, Berkeley, California 94720, United States.
- Novartis-Berkeley Translational Chemical Biology Institute, Berkeley, California 94720, United States.
- Innovative Genomics Institute, Berkeley, California 94720, United States.
- Novartis Biomedical Research, Emeryville, California 94608, United States.
- Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, California 94720, United States.
ORCID-Profile: James W Papatzimas, Daniel K Nomura
Förderung
- NCI NIH HHS
- NIH HHS
- Division of Chemistry
- National Cancer Institute
- Novartis Institutes for BioMedical Research
- Mark Foundation For Cancer Research
Zitieren
APA
Lim, M., Cong, T. D., Orr, L. M., Toriki, E. S., Kile, A. C., Papatzimas, J. W., Lee, E., Lin, Y., & Nomura, D. K. (2024). DCAF16-Based Covalent Handle for the Rational Design of Monovalent Degraders. ACS Central Science, 10(7), 1318-1331. https://doi.org/10.1021/acscentsci.4c00286
Vancouver
Lim M, Cong TD, Orr LM, Toriki ES, Kile AC, Papatzimas JW, et al. DCAF16-Based Covalent Handle for the Rational Design of Monovalent Degraders. ACS Central Science. 2024;10(7):1318-1331. doi:10.1021/acscentsci.4c00286
BibTeX
@article{Lim2024,
author = {Lim, Melissa and Cong, Thang Do and Orr, Lauren M and Toriki, Ethan S and Kile, Andrew C and Papatzimas, James W and Lee, Elijah and Lin, Yihan and Nomura, Daniel K},
title = {DCAF16-Based Covalent Handle for the Rational Design of Monovalent Degraders},
journal = {ACS Central Science},
year = {2024},
volume = {10},
number = {7},
pages = {1318--1331},
doi = {10.1021/acscentsci.4c00286}
}
EUVIMED